Your browser doesn't support javascript.
loading
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aß, tau, immunity and lipid processing.
Kunkle, Brian W; Grenier-Boley, Benjamin; Sims, Rebecca; Bis, Joshua C; Damotte, Vincent; Naj, Adam C; Boland, Anne; Vronskaya, Maria; van der Lee, Sven J; Amlie-Wolf, Alexandre; Bellenguez, Céline; Frizatti, Aura; Chouraki, Vincent; Martin, Eden R; Sleegers, Kristel; Badarinarayan, Nandini; Jakobsdottir, Johanna; Hamilton-Nelson, Kara L; Moreno-Grau, Sonia; Olaso, Robert; Raybould, Rachel; Chen, Yuning; Kuzma, Amanda B; Hiltunen, Mikko; Morgan, Taniesha; Ahmad, Shahzad; Vardarajan, Badri N; Epelbaum, Jacques; Hoffmann, Per; Boada, Merce; Beecham, Gary W; Garnier, Jean-Guillaume; Harold, Denise; Fitzpatrick, Annette L; Valladares, Otto; Moutet, Marie-Laure; Gerrish, Amy; Smith, Albert V; Qu, Liming; Bacq, Delphine; Denning, Nicola; Jian, Xueqiu; Zhao, Yi; Del Zompo, Maria; Fox, Nick C; Choi, Seung-Hoan; Mateo, Ignacio; Hughes, Joseph T; Adams, Hieab H; Malamon, John.
Afiliación
  • Kunkle BW; John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA. bkunkle@miami.edu.
  • Grenier-Boley B; Inserm, U1167, RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, Lille, France.
  • Sims R; Institut Pasteur de Lille, Lille, France.
  • Bis JC; Univ. Lille, U1167-Excellence Laboratory LabEx DISTALZ, Lille, France.
  • Damotte V; Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Naj AC; UK Dementia Research Institute at Cardiff, Cardiff University, Cardiff, UK.
  • Boland A; Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Vronskaya M; Inserm, U1167, RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, Lille, France.
  • van der Lee SJ; Institut Pasteur de Lille, Lille, France.
  • Amlie-Wolf A; Univ. Lille, U1167-Excellence Laboratory LabEx DISTALZ, Lille, France.
  • Bellenguez C; Department of Biostatistics and Epidemiology/Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Frizatti A; Centre National de Recherche en Génomique Humaine, Institut de Biologie François Jacob, CEA, Université Paris-Saclay, and LabEx GENMED, Evry, France.
  • Chouraki V; Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Martin ER; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Sleegers K; Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Badarinarayan N; Inserm, U1167, RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, Lille, France.
  • Jakobsdottir J; Institut Pasteur de Lille, Lille, France.
  • Hamilton-Nelson KL; Univ. Lille, U1167-Excellence Laboratory LabEx DISTALZ, Lille, France.
  • Moreno-Grau S; Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Olaso R; Inserm, U1167, RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, Lille, France.
  • Raybould R; Institut Pasteur de Lille, Lille, France.
  • Chen Y; Univ. Lille, U1167-Excellence Laboratory LabEx DISTALZ, Lille, France.
  • Kuzma AB; Framingham Heart Study, Framingham, MA, USA.
  • Hiltunen M; Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
  • Morgan T; John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Ahmad S; Neurodegenerative Brain Diseases Group, Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Vardarajan BN; Laboratory for Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Epelbaum J; Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Hoffmann P; Icelandic Heart Association, Kopavogur, Iceland.
  • Boada M; John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Beecham GW; Research Center and Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades-Universitat Internacional de Catalunya, Barcelona, Spain.
  • Garnier JG; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
  • Harold D; Centre National de Recherche en Génomique Humaine, Institut de Biologie François Jacob, CEA, Université Paris-Saclay, and LabEx GENMED, Evry, France.
  • Fitzpatrick AL; Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Valladares O; UK Dementia Research Institute at Cardiff, Cardiff University, Cardiff, UK.
  • Moutet ML; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • Gerrish A; Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Smith AV; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
  • Qu L; Department of Neurology, Kuopio University Hospital, Kuopio, Finland.
  • Bacq D; Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Denning N; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Jian X; Taub Institute on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University, New York, NY, USA.
  • Zhao Y; Gertrude H. Sergievsky Center, Columbia University, New York, NY, USA.
  • Del Zompo M; Department of Neurology, Columbia University, New York, NY, USA.
  • Fox NC; UMR 894, Center for Psychiatry and Neuroscience, Inserm, Université Paris Descartes, Paris, France.
  • Choi SH; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Mateo I; Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
  • Hughes JT; Division of Medical Genetics, University Hospital and Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Adams HH; Research Center and Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades-Universitat Internacional de Catalunya, Barcelona, Spain.
  • Malamon J; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
Nat Genet ; 51(3): 414-430, 2019 03.
Article en En | MEDLINE | ID: mdl-30820047
ABSTRACT
Risk for late-onset Alzheimer's disease (LOAD), the most prevalent dementia, is partially driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association meta-analysis of clinically diagnosed LOAD (94,437 individuals). We confirm 20 previous LOAD risk loci and identify five new genome-wide loci (IQCK, ACE, ADAM10, ADAMTS1, and WWOX), two of which (ADAM10, ACE) were identified in a recent genome-wide association (GWAS)-by-familial-proxy of Alzheimer's or dementia. Fine-mapping of the human leukocyte antigen (HLA) region confirms the neurological and immune-mediated disease haplotype HLA-DR15 as a risk factor for LOAD. Pathway analysis implicates immunity, lipid metabolism, tau binding proteins, and amyloid precursor protein (APP) metabolism, showing that genetic variants affecting APP and Aß processing are associated not only with early-onset autosomal dominant Alzheimer's disease but also with LOAD. Analyses of risk genes and pathways show enrichment for rare variants (P = 1.32 × 10-7), indicating that additional rare variants remain to be identified. We also identify important genetic correlations between LOAD and traits such as family history of dementia and education.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos beta-Amiloides / Proteínas tau / Predisposición Genética a la Enfermedad / Sitios Genéticos / Enfermedad de Alzheimer / Inmunidad / Lípidos Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Aged / Female / Humans / Male Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos beta-Amiloides / Proteínas tau / Predisposición Genética a la Enfermedad / Sitios Genéticos / Enfermedad de Alzheimer / Inmunidad / Lípidos Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Aged / Female / Humans / Male Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos